Mechanisms and therapeutic insights into MASH-associated fibrosis
{{output}}
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease posing a major global health concern, closely related to the rising prevalence of obesity. Liver fibrosis is the primary determinant of adverse outcomes in MASH. The increas... ...
